menu
    • menu

    Company profile for Santhera Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are focusing on the development of treatments for neuro-ophthalmological, neuromuscular and pulmonary diseases that currently lack treatment options, such as Leber's hereditary optic neuropathy (LHON), Duchenne muscular dystrophy (DMD), congenital muscular dystrophy (CMD) and cystic fibrosis (CF).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Santhera PharmaceuticalsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Hohenrainstrasse 24 4133 Pratteln
    Telephone
    Telephone
    +41 61 906 89 50
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.santhera.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Santhera Closes USD 13 Million Royalty Monetization Agreement
    Santhera Closes USD 13 Million Royalty Monetization Agreement

    05 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-05/santhera-closes-usd-13-million-royalty-monetization-agreement

    PHARMIWEB
    05 Nov 2025
    Share Share
    AGAMREE (Vamorolone) Shows Safer Profile In DMD Patients
    AGAMREE (Vamorolone) Shows Safer Profile In DMD Patients

    04 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-04/five-year-data-of-agamree-vamorolone-in-patients-with-dmd-show-improved-safety-profile-with-comparable-effectiveness-to-standard-of-care-corticoste

    PHARMIWEB
    04 Nov 2025
    Share Share
    Santhera Partners Biomedica For AGAMREE® Distribution In Russia
    Santhera Partners Biomedica For AGAMREE® Distribution In Russia

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3163838/0/en/Santhera-Secures-Agreement-with-Biomedica-for-the-Distribution-of-AGAMREE-Vamorolone-in-Russia.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share
    Santhera Gets Canada Approval For AGAMREE® In DMD
    Santhera Gets Canada Approval For AGAMREE® In DMD

    03 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/03/3160773/0/en/Santhera-Announces-Approval-in-Canada-for-AGAMREE-Vamorolone-as-a-Treatment-for-Duchenne-Muscular-Dystrophy.html

    GLOBENEWSWIRE
    03 Oct 2025
    Share Share
    Santhera Updates On Convertible Bond Issued In September 2025
    Santhera Updates On Convertible Bond Issued In September 2025

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3155966/0/en/Santhera-Provides-Update-on-Convertible-Bond-Issued-on-23-September-2025.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Santhera, Ikris Ink Deal to Distribute AGAMREE in India
    Santhera, Ikris Ink Deal to Distribute AGAMREE in India

    29 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/santhera-ikris-sign-agreement-for-distribution-of-agamree-in-india/

    CONTRACTPHARMA
    29 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search